These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 36911732)

  • 1. The effects of microglia-associated neuroinflammation on Alzheimer's disease.
    Wang C; Zong S; Cui X; Wang X; Wu S; Wang L; Liu Y; Lu Z
    Front Immunol; 2023; 14():1117172. PubMed ID: 36911732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc utilization by microglia in Alzheimer's disease.
    Shippy DC; Oliai SF; Ulland TK
    J Biol Chem; 2024 May; 300(5):107306. PubMed ID: 38648940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
    Webers A; Heneka MT; Gleeson PA
    Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
    Cai Z; Hussain MD; Yan LJ
    Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches.
    Yassaghi Y; Nazerian Y; Ghasemi M; Nazerian A; Sayehmiri F; Perry G; Gholami Pourbadie H
    J Cell Mol Med; 2024 Aug; 28(15):e18554. PubMed ID: 39103747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial activation occurs late during preclinical Alzheimer's disease.
    Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
    Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
    Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
    Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease.
    Al-Ghraiybah NF; Wang J; Alkhalifa AE; Roberts AB; Raj R; Yang E; Kaddoumi A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
    Leng F; Edison P
    Nat Rev Neurol; 2021 Mar; 17(3):157-172. PubMed ID: 33318676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets.
    AmeliMojarad M; AmeliMojarad M
    CNS Neurosci Ther; 2024 Jul; 30(7):e14856. PubMed ID: 39031970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.
    Melah KE; Lu SY; Hoscheidt SM; Alexander AL; Adluru N; Destiche DJ; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Gleason CE; Dowling NM; Bratzke LC; Rowley HA; Sager MA; Asthana S; Johnson SC; Bendlin BB
    J Alzheimers Dis; 2016; 50(3):873-86. PubMed ID: 26836182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation.
    Chen Y; Yu Y
    J Neuroinflammation; 2023 Jul; 20(1):165. PubMed ID: 37452321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer's disease.
    Xie Z; Meng J; Kong W; Wu Z; Lan F; Narengaowa ; Hayashi Y; Yang Q; Bai Z; Nakanishi H; Qing H; Ni J
    Aging Cell; 2022 Mar; 21(3):e13565. PubMed ID: 35181976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain resident microglia in Alzheimer's disease: foe or friends.
    Kaur S; K M; Sharma A; Giridharan VV; Dandekar MP
    Inflammopharmacology; 2024 Oct; 32(5):2781-2800. PubMed ID: 39167311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer's disease mouse model.
    Freitag K; Sterczyk N; Wendlinger S; Obermayer B; Schulz J; Farztdinov V; Mülleder M; Ralser M; Houtman J; Fleck L; Braeuning C; Sansevrino R; Hoffmann C; Milovanovic D; Sigrist SJ; Conrad T; Beule D; Heppner FL; Jendrach M
    J Neuroinflammation; 2022 Jul; 19(1):172. PubMed ID: 35780157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
    Minter MR; Taylor JM; Crack PJ
    J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.